Literature DB >> 18057135

Development of a species-specific fur gene-based method for identification of the Burkholderia cepacia complex.

Karlene H Lynch1, Jonathan J Dennis.   

Abstract

Burkholderia is an important bacterial genus with a complex taxonomy that contains species of both ecological and pathogenic importance, including nine closely related species collectively termed the Burkholderia cepacia complex (BCC). Unfortunately, 16S rRNA gene analysis has proven to be not sensitive enough to discriminate between species of the BCC. Alternative species identification strategies such as recA-based PCR followed by restriction fragment length polymorphism analysis, although initially useful, have proven to be inaccurate with the increasing species diversity of the BCC. recA gene sequence analysis is more discriminatory and corroborates other biochemical and polyphasic means of taxonomic differentiation. However, it is limited by the fact that certain BCC species are subdivided into discrete recA sequence subgroups that may confuse clinical diagnoses. In this study, an effective approach is described for the rapid differentiation of BCC species from both environmental and clinical sources by means of a single-locus sequencing and PCR assay using fur as a target gene that provides sequence phylogenies that are species specific and, with few exceptions, not divided into subspecies clusters. This assay is specific and can be used to correctly determine the species status of BCC strains tested following sequencing and amplification of the fur gene by both general and species-specific primers. Based on our results, this typing strategy is simpler than and as sensitive as established tests currently in use clinically. This assay is useful for the rapid, definitive identification of all nine current BCC species and potentially novel species groups.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18057135      PMCID: PMC2238088          DOI: 10.1128/JCM.01460-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  35 in total

1.  Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex.

Authors:  E Mahenthiralingam; T Coenye; J W Chung; D P Speert; J R Govan; P Taylor; P Vandamme
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex.

Authors:  D A Henry; E Mahenthiralingam; P Vandamme; T Coenye; D P Speert
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

Review 3.  Taxonomy and identification of the Burkholderia cepacia complex.

Authors:  T Coenye; P Vandamme; J R Govan; J J LiPuma
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

4.  Revised approach for identification of isolates within the Burkholderia cepacia complex and description of clinical isolates not assigned to any of the known genomovars.

Authors:  Jane F Turton; Nazia Arif; Daneeta Hennessy; Mary E Kaufmann; Tyrone L Pitt
Journal:  J Clin Microbiol       Date:  2007-07-11       Impact factor: 5.948

5.  Outbreak of subclinical mastitis in a flock of dairy sheep associated with Burkholderia cepacia complex infection.

Authors:  E Berriatua; I Ziluaga; C Miguel-Virto; P Uribarren; R Juste; S Laevens; P Vandamme; J R Govan
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

6.  Misidentification of a genomovar of Burkholderia cepacia by recA restriction fragment length polymorphism.

Authors:  J E Moore; B C Millar; J Xu; M Crowe; A O B Redmond; J S Elborn
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

7.  DNA-Based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III.

Authors:  E Mahenthiralingam; J Bischof; S K Byrne; C Radomski; J E Davies; Y Av-Gay; P Vandamme
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

8.  Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates.

Authors:  J D McMenamin; T M Zaccone; T Coenye; P Vandamme; J J LiPuma
Journal:  Chest       Date:  2000-06       Impact factor: 9.410

9.  Comparative assessment of genotyping methods for epidemiologic study of Burkholderia cepacia genomovar III.

Authors:  Tom Coenye; Theodore Spilker; Alissa Martin; John J LiPuma
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

10.  Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada.

Authors:  David P Speert; Deborah Henry; Peter Vandamme; Mary Corey; Eshwar Mahenthiralingam
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

View more
  13 in total

1.  Unusual distribution of Burkholderia cepacia complex species in Danish cystic fibrosis clinics may stem from restricted transmission between patients.

Authors:  Niels Nørskov-Lauritsen; Helle Krogh Johansen; Mette G Fenger; Xiaohui C Nielsen; Tacjana Pressler; Hanne V Olesen; Niels Høiby
Journal:  J Clin Microbiol       Date:  2010-06-02       Impact factor: 5.948

Review 2.  Burkholderia cepacia Complex Bacteria: a Feared Contamination Risk in Water-Based Pharmaceutical Products.

Authors:  Mariana Tavares; Mariya Kozak; Alexandra Balola; Isabel Sá-Correia
Journal:  Clin Microbiol Rev       Date:  2020-04-15       Impact factor: 26.132

3.  Identification and characterization of ϕH111-1: A novel myovirus with broad activity against clinical isolates of Burkholderia cenocepacia.

Authors:  Karlene H Lynch; Yongjie Liang; Leo Eberl; David S Wishart; Jonathan J Dennis
Journal:  Bacteriophage       Date:  2013-10-01

4.  rpsU-based discrimination within the genus Burkholderia.

Authors:  H Frickmann; H Neubauer; U Loderstaedt; H Derschum; R M Hagen
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2014-05-21

5.  A sensitive & specific multiplex PCR assay for simultaneous detection of Bacillus anthracis, Yersinia pestis, Burkholderia pseudomallei & Brucella species.

Authors:  Sai Arun Batra; S Krupanidhi; Urmil Tuteja
Journal:  Indian J Med Res       Date:  2013       Impact factor: 2.375

6.  Comparison of Mast Burkholderia Cepacia, Ashdown + Gentamicin, and Burkholderia Pseudomallei Selective Agar for the Selective Growth of Burkholderia Spp.

Authors:  Carola Edler; Henri Derschum; Mirko Köhler; Heinrich Neubauer; Hagen Frickmann; Ralf Matthias Hagen
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2017-01-09

7.  Genomic sequence and activity of KS10, a transposable phage of the Burkholderia cepacia complex.

Authors:  Amanda D Goudie; Karlene H Lynch; Kimberley D Seed; Paul Stothard; Savita Shrivastava; David S Wishart; Jonathan J Dennis
Journal:  BMC Genomics       Date:  2008-12-18       Impact factor: 3.969

8.  Polyclonal outbreak of bloodstream infections caused by Burkholderia cepacia complex in hematology and bone marrow transplant outpatient units.

Authors:  Icaro Boszczowski; Gladys Villas Boas do Prado; Mirian F Dalben; Roberto C P Telles; Maristela Pinheiro Freire; Thaís Guimarães; Maura S Oliveira; Juliana F Rosa; Robson E Soares; Pedro Enrique Dorlhiac Llacer; Frederico Luiz Dulley; Silvia F Costa; Anna S Levin
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Jan-Feb       Impact factor: 1.846

9.  Identification and molecular epidemiology of nosocomial outbreaks due to Burkholderia cepacia in cystic fibrosis patients of Masih Daneshvary Hospital, Iran.

Authors:  M M Soltan Dallal; C F Telefian; M Hajia; E Kalantar; A R Dolatyar Dehkharghani; A Rahimi Forushani; Q Khanbabaei; M Mobarhan; M R Farzami
Journal:  J Prev Med Hyg       Date:  2014-03

10.  Correlation of rpsU Gene Sequence Clusters and Biochemical Properties, Gc-Ms Spectra and Resistance Profiles of Clinical Burkholderia Spp. Isolates.

Authors:  Maria Franziska Ostermann; Heinrich Neubauer; Hagen Frickmann; Ralf Matthias Hagen
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2016-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.